# $fbio

ZYCUBO has been approved, but concerns are rising about the lack of a significant PRV, potentially impacting investment theses. PDUFA updates continue to be a major focus for the biotech community.

### About $fbio
$FBIO refers to a social media platform and its associated community, likely focused on biotechnology and pharmaceutical discussions.  

### Engagements: [---] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$fbio/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$fbio/time-series/interactions.tsv)  
Current Value: [---]  
Daily Average: [-----]  
[--] Month: [------] -58%  
[--] Months: [-------] +131%  
[--] Year: [---------] +183%  
1-Year High: [------] on 2025-10-01  
1-Year Low: [---] on 2025-04-13  

Engagements by network (24h):
Reddit: [--]
YouTube: [--]
X: [---]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$fbio/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$fbio/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
1-Year High: [---] on 2025-12-17  
1-Year Low: [--] on 2025-10-27  

Mentions by network (24h):
Reddit: [--]
YouTube: [--]
X: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$fbio/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$fbio/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning $fbio in the last [--] hours which is up 5% from [--] in the previous [--] hours
Daily Average: [--]  
1-Year High: [---] on 2025-12-17  
1-Year Low: [--] on 2025-04-29  
  
  
### Sentiment: 80%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$fbio/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$fbio/time-series/sentiment.tsv)  
Current Value: 80%  
Daily Average: 87%  
[--] Month: 83% -1%  
[--] Months: 83% -17%  
[--] Year: 83% -17%  
1-Year High: 100% on 2025-02-16  
1-Year Low: 6% on 2025-12-09  

Most Supportive Themes:
- PDUFA Updates: (67%) This theme covers upcoming and recent FDA decisions on biotech drugs, including approvals and rejections.
  
Most Critical Themes:
- ZYCUBO Approval & PRV Concerns: (33%) This theme highlights the approval of ZYCUBO but questions the absence of a significant PRV, suggesting a potential miscalculation in investment thesis.

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing